Par Drugs and Chemicals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
For the six months, sales was INR 488.22 million compared to INR 483.25 million a year ago. Revenue was INR 488.83 million compared to INR 484.94 million a year ago. Net income was INR 73.59 million compared to INR 60.19 million a year ago. Basic earnings per share from continuing operations was INR 5.98 compared to INR 4.89 a year ago. Diluted earnings per share from continuing operations was INR 5.98 compared to INR 4.89 a year ago.